Last update:

Oncology & Cancer news

Oncology & Cancer

Survey finds one in three patients needed more information on cancer treatment side effects

One in three adults treated for cancer may experience side effects from treatment they wish they had known more about, according to a new survey published - link will be live when embargo lifts] today in the Journal of Oncology ...

Oncology & Cancer

How do gliomas evolve?

The Glioma Longitudinal Analysis (GLASS) Consortium characterized diffuse glioma cells both before and after therapy to characterize how they change and why this form of malignant brain cancer is so difficult to treat. The ...

Oncology & Cancer

Cancer yield similar for dense breast ultrasound after DM, DBT

(HealthDay)—There is no significant difference in breast cancer detection rates with dense breast ultrasound screening following digital mammography (DM) versus digital breast tomosynthesis (DBT), according to a study recently ...

Oncology & Cancer

Researchers identify new gene mutation in familial thyroid cancers

Researchers from Penn State College of Medicine identified a new gene mutation that may cause a type of familial thyroid cancer. Dr. Darrin Bann, an otolaryngology resident at the College of Medicine and lead author of the ...

Medical research

New cancer treatment not as toxic as others

A QIMR Berghofer study has identified how a newly approved blood cancer drug works and found the treatment is better than other drugs at targeting cancer stem cells while causing minimal damage to healthy cells.

Oncology & Cancer

Breast cancer recurrence score has different implications for men

The TAILORx study published last year offered good news for women with early-stage ER-positive breast cancer who scored at intermediate risk for recurrence according to a genetic assay test. The study indicated that chemotherapy ...

Oncology & Cancer

Twenty five years of learning to combat cervical cancer

According to the World Health Organization, cervical cancer is the fourth most common type of cancer affecting women worldwide. Currently, early screenings of pre-cancerous tissues and vaccination have proven to be the most ...

Oncology & Cancer

Milestone reached in new leukemia drug

Cold Spring Harbor Laboratory scientists, with chemists and cancer biologists from Dana-Farber Cancer Institute (DFCI), have developed a new therapy that extended the survival of mice with acute myeloid leukemia.

Medical research

Cell death or cancer growth: A question of cohesion

Activation of CD95, a receptor found on all cancer cells, triggers programmed cell death—or does the opposite, namely stimulates cancer cell growth. Scientists from the German Cancer Research Center (DKFZ) have now shown ...